Gateway 2011: Labconco Corporation - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Gateway 2011: Labconco Corporation



Your online Gateway to Labconco Corporation in 2011

8811 Prospect Avenue
Kansas City, MO 64132
800-821-5525/816-333-8811
Fax: 816-363-0130
www.labconco.com

Labconco has been manufacturing laboratory equipment since 1925. We sell through a worldwide network of laboratory supply distributors. Our laboratory equipment is marketed to pharmaceutical, industrial, life science, environmental, clinical and crime laboratories. The wide variety of products include biological safety cabinets, fume hoods, glove boxes, glassware washers, freeze dry systems, carbon-filtered enclosures, balance enclosures, bulk powder enclosures, laboratory animal research enclosures, evaporation systems and centrifugal concentrators. Three of Labconco’s major product lines contribute toward LEED credits: fume hoods, biosafety cabinets, and glassware washers. Labconco is ISO 9001 certified and is a member of the USGBC.

<

Protector® Filtered Glove Boxes provide inlet and outlet HEPA or ULPA filtration and a leak-tight physical barrier to protect the operator from exposure to potentially hazardous materials. 

The FreeZone® -105°C 4.5 Liter Benchtop Freeze Dry Systems have ice holding capacity for light to moderate loads and have dual refrigeration systems for samples with very low eutectic points.

 

New Products
and Releases
New Whitepapers

FreeZone® -105°C 4.5 Liter Benchtop Freeze Dry Systems

New -105˚C FreeZone® Freeze Dry System
  NEW Protector® Glove Boxes
   



ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
28%
Oversee medical treatment of patients in the US.
9%
Provide treatment for patients globally.
9%
All of the above.
41%
No government involvement in patient treatment or drug development.
13%
Jim Miller Outsourcing Outlook Jim MillerCMO Industry Thins Out
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerFluorination Remains Key Challenge in API Synthesis
Marilyn E. Morris Guest EditorialMarilyn E. MorrisBolstering Graduate Education and Research Programs
Jill Wechsler Regulatory Watch Jill Wechsler Biopharma Manufacturers Respond to Ebola Crisis
Sean Milmo European Regulatory WatchSean MilmoHarmonizing Marketing Approval of Generic Drugs in Europe
FDA Reorganization to Promote Drug Quality
FDA Readies Quality Metrics Measures
New FDA Team to Spur Modern Drug Manufacturing
From Generics to Supergenerics
CMOs and the Track-and-Trace Race: Are You Engaged Yet?

Click here